AGORA Cancer Research Center
AGORA was inspired by the vision that the integration of progress in cancer research into clinical practice can be accelerated by bringing together interdisciplinary research teams of clinicians, cancer biologists, immunologists, bio-informaticians and bio-engineers. Initiated by the ISREC Foundation in 2013, the AGORA building was opened in 2018. The functioning of this translational cancer research center reflects a partnership between the Lausanne University Hospital (CHUV), the University of Lausanne (UNIL), the Swiss Federal Institute of Technology of Lausanne (EPFL), the University Hospitals of Geneva (HUG) and the University of Geneva (UNIGE).
Latest news
Events
Lola and John Grace Distinguished Lecture in Cancer Research, Dr Meritxell Huch | September 2nd
Events
Oncology Grand Rounds, Dr. Olivia Le Saux | September 4th
Events
AGORA BBQ | September 10th
Events
DOF Seminar, Antony Carrard | September 15th
Events
FBM Opening Ceremony of the 2026–2027 Academic Year | September 16th
Events
Inaugural Lecture of Prof. Etienne Meylan | September 28th
Events
EPFL Latsis Symposium 2026 | October 29-30
Latest publications
Challenges in the use of the European Society for Radiotherapy and Oncology-European Organisation for Research and Treatment of Cancer oligometastatic disease classification system in ovarian cancer.
Macchia G, Morganti AG, Taylor A, (…), Herrera FG, Jereczek-Fossa BA, Guckenberger M
The Lancet. Oncology – 2026 Sep
Baseline interferon signaling in monocytes and antibody-mediated innate activation are associated with reactogenicity to mRNA vaccines.
Madelon N, Ruiz Buendía GA, Torres Rodriguez P, (…), Harmon C, DiPiazza A, Didierlaurent AM
Science translational medicine – 2026 Aug 26
Beyond benchmarking: an expert-guided consensus approach to spatially aware clustering.
Sun J, Biharie K, Cai P, (…), Mahfouz A, Robinson MD, Ishaque N
Nature methods – 2026 Aug 24
CXCR4-Targeted Molecular Imaging in Hematology and Oncology.
Werner RA, Buck AK, Haug A, (…), Keller U, Kobe C, Gotthardt M
Journal of nuclear medicine – 2026 Aug 13
Management of systemic lupus erythematosus and antiphospholipid syndrome during CAR-T therapy: insights from two clinical cases.
Normand C, Almaz S, Stadelmann R, (…), Arber C, Ghisoni E, Le Moine M
Immuno-oncology technology – 2026 Aug 10